法兰克福, 2019年6月6日. The M&A Advisor 于6月5日星期三在纽约颁发了第11届国际奖的获奖者。 由ACXIT Capital Partners担任顾问的向Zur Rose集团出售medpex线上业务的交易被评为年度医疗保健 / 生命科学交易。
更多信息ACXIT CAPITAL PARTNERS ADVISED EUROPEAN HEALTHCARE PRIVATE EQUITY SPECIALIST ARCHIMED ON THE ACQUISITION OF ITALIAN IN VITRO DIAGNOSTICS COMPANY DIESSE DIAGNOSTICA SPA
Frankfurt, 29 May 2019. On May 22, 2019, ArchiMed announced the purchase of Diesse Diagnostica Senese SpA (‘Diesse’) by Duomodiag Sarl, a holding company backed by ArchiMed through its MED II fund, with bank finance provided by leading Italian banks MPS Capital Services and BPER. The transaction was completed on May 13, 2019. Diesse was acquired from its founders and from Orphée SA, the Swiss subsidiary of Warsaw listed diagnostics group PZ Cormay SA.
更多信息SUCCESSFUL SALE OF LANGENSCHEIDT PUBLISHING PROGRAM TO PONS (KLETT PUBLISHING GROUP)
Munich, 06 May 2019. PONS GmbH has acquired the publishing rights of Langenscheidt GmbH & Co. KG and Langenscheidt Digital GmbH & Co. KG. The titles and products will be integrated in the current publishing program of PONS. The Langenscheidt brand, thus, remains in the market.
更多信息Acxit Capital Partners promotes Ruta Hildebrand and Tobias Warkus to Managing Directors
Frankfurt, 29 April 2019. ACXIT Capital Partners, a leading independent European corporate finance and investment advisory firm, is pleased to announce the appointment of two new Managing Directors: Ruta Hildebrand and Tobias Warkus have successfully executed numerous transactions at ACXIT and will strongly contribute to ACXIT’s further growth in their new positions. Both will accelerate the strategic expansion of ACXIT within their respective sectors.
更多信息ACXIT Capital Partners AG act as Fairness Opinion Provider to Lotto24’s Supervisory Board and Executive Board in the context of the voluntary public offer of ZEAL Network for all outstanding shares of Lotto24
Zurich, 07 March 2019. On 19 November 2018, ZEAL Network SE (“ZEAL”), a company listed on the Prime Standard sub-segment of the regulated market of the Frankfurt Stock Exchange (“FSE”), with a market capitalization of EUR 197.0m as of 11 February 2019, launched a voluntary public takeover offer (“Public Offer” or the “Transaction”) according to section 10 section 1 sentence 1 of the German Securities Acquisition and Takeover Act for all outstanding shares of Lotto24 AG (“Lotto24” or “the Company”), also listed on the FSE, with a market capitalization of EUR 322.2m as of 11 February 2019.
更多信息Automotive supplier AUER GUSS rescued in less than 3 months
Amberg, 28 February 2019. Dr. Hubert Ampferl, Partner of law firm Dr. Beck & Partner, successfully concludes the sale of AUER GUSS Group.
更多信息ACXIT Capital Partners advises Tejado GmbH (“Brille24”) and its shareholders on the trade sale to French eyewear giant Essilor
Frankfurt, 14 February 2019. Essilor accelerates its digital strategy with the acquisition of Germany-based Brille24, a leading optical e-commerce platform.
更多信息High Speed M&A process for BEV – Deal with eco-power supplier Lichtblick
Munich, 12 February 2019. Due to the insolvency of Bayerische Energieversorgungsgesellschaft (BEV), almost half a million customers lost their electricity provider overnight. Now, preliminary administrator Axel Bierbach of law firm MHBK has reached an agreement with eco-power provider Lichtblick.
更多信息FIT FOR FUTURE BUSINESS: SCHUFA ACQUIRED A MAJORITY STAKE IN FINAPI GMBH
Frankfurt, 11 February 2019. Fintech company finAPI GmbH, founded in 2008, and SCHUFA Holding AG will closely collaborate in the Access to Account (X2SA) solutions segment in the future. To substantiate this partnership, SCHUFA acquired a majority stake in finAPI in December 2018. finAPI will continue to operate independently.
更多信息ACXIT Capital Partners opens New York office and welcomes Dr. Michael W. Ernestus as head of its U.S. practice
Frankfurt, 06 February 2019. ACXIT Capital Partners, a leading independent European corporate finance and investment advisory firm, is pleased to announce its office opening in New York, and the addition of Managing Partner Dr. Michael W. Ernestus to head its transatlantic practice.
更多信息
